Skip to main content
Medical Reference · Condition Monograph

Spinal Tumor

척추종양

Spinal tumor is a general term for tumors that arise in the vertebrae (vertebral bodies), the spinal cord, or around the membranes surrounding the spinal cord and the nerve roots.

History

Spinal tumor is a general term for tumors that arise in the vertebrae (vertebral bodies), the spinal cord, or around the membranes surrounding the spinal cord and the nerve roots. In the past, these were often understood loosely as “low back pain of unknown cause” or “paralysis,” and it was difficult to confirm that a tumor was inside the spine. Neurological examination and plain X-rays provided clues only when the bone was severely damaged, and tumors arising in the spinal cord itself were difficult to confirm until surgery was performed.

Advances in imaging technology changed the course of spinal tumor care. Computed tomography better showed bone destruction, pathological fractures, and tumorous lesions narrowing the spinal canal, and magnetic resonance imaging showed relatively accurately the spinal cord, nerve roots, the extent of the tumor, and even changes such as edema and hemorrhage, establishing a system for classifying “which tumor is where” by location. The classification that divides tumors into those outside the dura (extradural) and inside the dura (intradural), and further divides intradural tumors into those inside the spinal cord (intramedullary) and outside the spinal cord (extramedullary), remains central today for determining treatment strategy (surgical approach, radiation therapy field).

The history of treating metastatic spinal tumors has also undergone great change. As cancer treatment outcomes improved and survival lengthened, the goal shifted from “treatment that only reduces pain” to “treatment that preserves function, maintains the ability to walk, and helps patients continue chemotherapy.” Recent research has emphasized that in metastatic patients with spinal cord compression, appropriately combining surgery and radiation therapy can help maintain function, and that precision radiation therapy (stereotactic body radiation therapy, etc.) can play an important role in pain and local tumor control. As concepts such as minimally invasive fixation and separation surgery (a strategy of securing space around the spinal cord and then delivering precision radiation) have spread, “multidisciplinary treatment” has come close to being the standard.

Causes

The causes of spinal tumors are easiest to understand when divided into two broad branches. The first is “primary tumors that begin in the spine.” These arise directly from the vertebrae, spinal cord, nerve sheath (the tissue wrapping the nerves), meninges, and so on. The second is “metastatic tumors in which cancer of another organ has spread to the spine.” Most extradural tumors are metastatic, and breast, prostate, lung, and kidney cancers are common primary cancers. In fact, when a spinal tumor is suspected in clinical practice, the first thing considered is whether it is a metastasis.

The clear causes of primary spinal cord and spinal tumors are usually unknown. However, some are related to genetic diseases. Neurofibromatosis type 1 is associated with neurofibromas, neurofibromatosis type 2 with meningiomas and schwannomas, and von Hippel–Lindau disease may be associated with hemangioblastomas.

For metastatic spinal tumors, “the biology of metastasis” is the cause. As cancer cells travel through the bloodstream and settle in the bone marrow space of the vertebrae, or spread through the venous network around the spine, they weaken the bone (lytic or sclerotic metastasis), and sometimes grow into the spinal canal and compress the spinal cord. Recent research has emphasized that in metastatic spinal cord compression, not only direct compression by the tumor but also inflammation, reduced blood flow, edema, and other factors can together worsen nerve damage.

Genetic Epidemiology

Because spinal tumor is not “a single disease” but a term grouping several types of tumors, the role of heredity also differs by tumor type. Metastatic spinal tumors basically follow the risk factors and biology of the primary cancer (breast cancer, lung cancer, etc.), and specific genes are not used in general practice in a way that directly predicts “spinal metastasis.”

On the other hand, in primary tumors, especially intradural tumors, genetic diseases can be an important clue. Neurofibromatosis type 1 is associated with neurofibromas, neurofibromatosis type 2 with meningiomas and schwannomas, and von Hippel–Lindau disease may be associated with hemangioblastomas. These diseases can be accompanied by a family history along with systemic findings such as skin findings (café-au-lait spots, etc.), hearing problems, and retinal or kidney lesions, so it is important to look at the whole picture rather than “only the spinal symptoms.”

Recent research shows that approaches such as molecular diagnosis, treatment based on gene mutations (targeted therapy), and immunotherapy are expanding for primary malignant spinal tumors. The key point to remember at the layperson's level is that “most spinal tumors are not explained by heredity alone, and genetic diseases can raise the risk in some specific tumor groups.” Therefore, when there is a family history or a related genetic disease is suspected, it is helpful to evaluate not only neurological symptoms (pain, paralysis) but also systemic clues together.

General Epidemiology

Spinal tumors differ in symptoms and frequency depending on their location. Extradural (outside the dura) tumors are the most common, and most of them are metastatic. In other words, the most common clinical situation for a spinal tumor is “a person who already has cancer developing spinal pain or neurological symptoms.” In contrast, intradural tumors are relatively rare, and among them, intradural extramedullary tumors outside the spinal cord (meningiomas, schwannomas) are known to be relatively easier to approach surgically than intramedullary tumors inside the spinal cord (ependymomas, astrocytomas).

Metastatic spinal tumors are a common complication in cancer patients; when the vertebrae weaken, pathological fractures and instability develop, and if the tumor grows into the spinal canal, it can lead to metastatic spinal cord compression. Recent research has emphasized that metastatic spinal cord compression can sharply reduce the quality of life of cancer patients and is a situation that must be handled as an emergency.

Primary vertebral tumors are rare overall, but they are diverse in type and their treatment strategies are complex. Recent research has emphasized the view that, to increase diagnostic accuracy, it is important for prognosis to systematically carry out whole-body imaging (e.g., combined positron emission tomography and magnetic resonance imaging), biopsy, and staging, and to secure the extent of surgery (radical resection removing the tumor in one piece when possible).

Pathogenesis

The mechanisms by which spinal tumors cause problems can be broadly divided into “the effect of occupying space and compressing” and “the effect of weakening bone.” Because the spinal cord and nerve roots pass through the narrow spinal canal and nerve openings, nerve structures can be compressed even if the tumor grows only slightly. The main symptoms of spinal tumors stem from spinal cord compression, in which case pain, reduced sensation, muscle weakness, and gait disturbance can occur, and as it progresses, bladder and bowel dysfunction can appear.

Intradural extramedullary tumors often compress the spinal cord “from the side” outside the cord, so they may begin with pain or symptoms of irritation of a specific nerve root. In contrast, intramedullary tumors grow in the spinal cord itself, so they damage the nerve pathways inside the cord and can produce sensory and motor deficits over a relatively wide range, and recovery may be limited.

Metastatic tumors settle in the bone marrow of the vertebrae and destroy the structure by dissolving bone (lytic) or making it abnormally hard (sclerotic). When the bone weakens, the pain becomes severe, pathological fractures occur with even small forces, and the fracture and tumor mass together can compress the spinal cord and nerves. Recent research has summarized that because metastatic spinal cord compression goes beyond simple compression and is accompanied by edema and impaired blood flow that can worsen nerve damage, rapid decompression, steroid use, and radiation therapy are important.

Symptoms

The most common symptom of spinal tumors is pain. Back or low back pain that worsens at night is the representative symptom. In particular, pain even at rest, pain that wakes one at night, and pain that gradually worsens can be warning signs. When the tumor presses on a nerve, the pain may radiate to the arms or legs, or appear as numbness and reduced sensation in a specific area.

As spinal cord compression progresses, muscle weakness and gait disturbance can appear. It may begin as the legs feeling heavy and dragging, difficulty going up and down stairs, or unsteady balance. Clumsiness of fine hand movements may suggest spinal cord compression in the neck. Sensory abnormalities may appear on the trunk, like “a band-like tightening sensation,” or a sensory level may appear, in which sensation is reduced below a certain height.

The emergency signs are bladder and bowel dysfunction and rapidly progressing paralysis. Loss of bladder and bowel control can appear at a late stage. In particular, if a person with a history of cancer has new low back pain together with a sudden drop in leg strength or difficulty controlling the bladder and bowels, the possibility of metastatic spinal cord compression should be considered first.

Signs

The signs that can be identified on physical examination differ depending on “what the tumor is pressing on.” When compression of a nerve root (a nerve going out to the periphery) predominates, weakness of specific muscles, reduced sensation in specific skin areas, and reflex changes may appear. When spinal cord compression predominates, upper motor neuron signs appear, such as exaggerated leg reflexes or spasticity, and gait may become stiff or balance may worsen.

When the vertebrae have weakened, there may be local tenderness when the area is pressed or tapped, and the pain may become severe with changes in posture. When the spine becomes unstable because of the tumor, mechanical pain that is “worse with movement and better when lying down” may be prominent.

In metastatic spinal cord compression, symptoms can worsen relatively quickly, and recent research has emphasized that early detection and rapid treatment are important for preserving the ability to walk. Therefore, if progressive muscle weakness, a sensory level, severe pain, or sphincter dysfunction is observed on examination, it should lead immediately to imaging evaluation.

Screening

Spinal tumor is not a condition for which regular screening of the general population has been established. Realistic screening is “screening based on risk groups and warning signs.” For example, if a person already diagnosed with cancer complains of new back or low back pain, or if it is accompanied by night pain, weight loss, fever, or neurological abnormalities (numbness, muscle weakness, gait disturbance), screening for the possibility of a spinal tumor should be done.

Also, even without a history of cancer, if pain persists for more than 6 weeks and gradually worsens, hurts regardless of rest, or is accompanied by neurological abnormalities, it is safer to consider a detailed evaluation rather than explaining it merely as a simple disc problem or muscle pain. In particular, night pain is one of the representative symptoms and can help distinguish it from ordinary musculoskeletal pain.

People suspected of having a genetic disease (neurofibromatosis, von Hippel–Lindau disease, etc.) may consider imaging tests at a lower threshold when neurological symptoms develop. However, universal testing of asymptomatic people can vary depending on individual risk and the medical team's judgment, and it is difficult to state as a general guideline.

Diagnosis

The core of diagnosis is imaging tests and tissue diagnosis. Magnetic resonance imaging is the imaging test of choice for spinal tumors. Magnetic resonance imaging clearly shows the spinal cord, nerve roots, the extent of the tumor, and spinal cord edema and degree of compression, and using a contrast agent allows the borders and active areas of the tumor to be seen more clearly. Computed tomography is advantageous for evaluating bone structure and helps in seeing pathological fractures, bone destruction, and the bone shape needed for surgical planning.

Evaluating for metastasis requires a whole-body evaluation. When the primary cancer is known, spinal imaging may be included as part of staging, and when the primary cancer is unclear, the primary site is searched for with blood tests and whole-body imaging. Recent research has continued to discuss that positron emission tomography can be used as a diagnostic aid, or that imaging combined with magnetic resonance imaging can help evaluate the extent of the tumor.

Biopsy is key to determining the direction of treatment. In particular, when a primary malignant tumor is suspected or it is unclear whether it is a metastasis, the type of tumor must be confirmed by biopsy. However, in situations where spinal cord compression is severe and nerve function is deteriorating rapidly, for safety the sequence may be to administer steroids first and obtain tissue while performing emergency decompression surgery.

Treatment

Treatment differs depending on the type of tumor (primary/metastatic, benign/malignant), its location (extradural/intradural), the patient's general condition, and the goal (cure/maintaining function/pain control). Surgery, radiation therapy, and chemotherapy are the basic pillars, and in some cases observation is possible.

In metastatic spinal cord compression, which is an emergency, “time” is important. Recent research has emphasized a multidisciplinary approach that reduces edema around the spinal cord with steroids and quickly decides on surgery or radiation therapy after rapid magnetic resonance imaging evaluation. Surgery serves to remove the tumor compressing the nerves or create room in the spinal canal (decompression), and to stabilize the weakened spine to reduce pain and instability. Radiation therapy is used to shrink local tumors, reduce pain, and control tumor remaining after surgery.

Recent research has summarized that stereotactic body radiation therapy or spinal stereotactic radiosurgery can be effective for pain and local control of metastatic spinal tumors and can deliver high doses while protecting nerve structures. For primary tumors, radical resection aimed at cure can be key, and the view has been emphasized that surgery removing the tumor in one piece when possible can reduce recurrence and favor survival. Spinal cord tumors (especially intramedullary) carry a high risk of nerve damage, so the extent of surgery is set as “maximal resection within a safe range” rather than “complete resection,” and radiation therapy or drug therapy is combined when necessary.

Prognosis

Prognosis depends greatly on whether the tumor is benign or malignant, primary or metastatic, and on the degree of nerve damage at the time of diagnosis. Benign intradural extramedullary tumors often have a good long-term prognosis if complete surgical resection is possible. In contrast, intramedullary tumors invade the spinal cord itself, so neurological deficits may remain even after surgery, and the risk of recurrence and the need for long-term management increase.

For metastatic spinal tumors, the goal is usually “maintaining function and controlling pain” rather than cure. Recent research has emphasized that in metastatic spinal cord compression, whether the patient can walk at the time of treatment is an important prognostic factor, and that early treatment increases the likelihood of maintaining the ability to walk. Even if local treatment goes well, overall survival is largely determined by the type of primary cancer and the response to chemotherapy.

An important change is also that, with advances in radiation therapy and surgery, pain control and preservation of nerve function have improved in many patients compared with the past. In addition, with the introduction of precision radiation therapy, reports have accumulated that treatment periods have become shorter and local recurrence can be reduced in some patients.

Prevention

Because spinal tumors are diverse in type and their causes are complex, it is difficult to offer “definite primary prevention” for the general population. However, for metastatic spinal tumors, early detection and treatment of the primary cancer, along with systemic treatment that lowers the risk of metastasis, effectively become the most important preventive strategy. In other words, the key is to lower the risk of primary cancer through quitting smoking, maintaining a healthy weight, vaccination, regular checkups, and so on, and, when cancer is diagnosed, to reduce metastasis through standard treatment.

From a practical perspective, “secondary prevention” of spinal tumors is early recognition and rapid evaluation. When night pain, pain unrelated to rest, gradually worsening pain, unexplained weight loss, and neurological symptoms such as numbness, muscle weakness, gait disturbance, and bladder and bowel dysfunction appear, early evaluation is important for reducing nerve damage. Recent research has also repeatedly emphasized that metastatic spinal cord compression must be handled as an emergency and that early diagnosis and treatment are important for preserving function.

For people with a genetic disease, follow-up observation suited to the characteristics of their condition can be part of prevention. Also, for patients undergoing cancer treatment, a realistic means of prevention is not to dismiss new low back pain as merely “a disc problem,” but to consult their medical team and check for the possibility of spinal metastasis.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.